Search for: "U.S. v. Price" Results 1 - 20 of 6,695
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 May 2024, 3:52 pm by Reference Staff
For scholarly publications, Rule 10.7.1(d) adds a descriptive parenthetical note for citing cases where an enslaved person was involved, and provides examples like “Wall v. [read post]
20 May 2024, 9:01 pm by renholding
While option awards initially predominated in U.S. private equity transactions, sponsors now often grant tax-advantaged profits interests to the U.S. members of their management teams, with various other approaches for the non-management members and foreign employees. [read post]
19 May 2024, 9:05 pm by The Regulatory Review
Sep 21, 2023 | HHS Selects Drugs for Medicare Price Negotiation | Biden Administration introduces price regulation to the pharmaceutical industry. [read post]
13 May 2024, 4:50 am by Franklin C. McRoberts
” In the case law, there is something of a presumption in favor of intervention: “Whether intervention is sought as a matter of right under CPLR 1012 (a), or as a matter of discretion under CPLR 1013, is of little practical significance since a timely motion for leave to intervene should be granted, in either event, where the intervenor has a real and substantial interest in the outcome of the proceedings” (Maggi v U.S. [read post]
6 May 2024, 9:01 pm by renholding
The FTC goes on to allege that Tapestry “intends to raise prices for Michael Kors through reducing discounts and promotions and pulling back on wholesale. [read post]